Paper27014261
Targeting Syk in Autoimmune Rheumatic Diseases.
Deng GM and 2 others. Front Immunol, 2016. Cited by 72 papers, by iCite.
Cite this record
ConductScience Library. Targeting Syk in Autoimmune Rheumatic Diseases. Papers, record 27014261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27014261
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20193005 | Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling. | Immunol Rev | 2010 | https://conductscience.org/library/papers/20193005 | PubMed |
| 2 | 20398308 | B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcgammaRIIb, which are modulated by anti-tumor necrosis factor therapy. | Arthritis Res Ther | 2010 | https://conductscience.org/library/papers/20398308 | PubMed |
| 3 | 7477352 | Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. | Nature | 1995 | https://conductscience.org/library/papers/7477352 | PubMed |
| 4 | 19306898 | Syk and pTyr'd: Signaling through the B cell antigen receptor. | Biochim Biophys Acta | 2009 | https://conductscience.org/library/papers/19306898 | PubMed |
| 5 | 21208113 | Spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21208113 | PubMed |
| 6 | 16498451 | Lymphoid neogenesis in chronic inflammatory diseases. | Nat Rev Immunol | 2006 | https://conductscience.org/library/papers/16498451 | PubMed |
| 7 | 23154170 | Structural and biophysical characterization of the Syk activation switch. | J Mol Biol | 2013 | https://conductscience.org/library/papers/23154170 | PubMed |
| 8 | 22040680 | Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis. | J Pharmacol Exp Ther | 2012 | https://conductscience.org/library/papers/22040680 | PubMed |
| 9 | 20201079 | Genetic deficiency of Syk protects mice from autoantibody-induced arthritis. | Arthritis Rheum | 2010 | https://conductscience.org/library/papers/20201079 | PubMed |
| 10 | 22796951 | Effect of locally administered Syk siRNA on allergen-induced arthritis and asthma. | Mol Immunol | 2013 | https://conductscience.org/library/papers/22796951 | PubMed |
| 11 | 22129255 | Systemic lupus erythematosus. | N Engl J Med | 2011 | https://conductscience.org/library/papers/22129255 | PubMed |
| 12 | 7477353 | Syk tyrosine kinase required for mouse viability and B-cell development. | Nature | 1995 | https://conductscience.org/library/papers/7477353 | PubMed |
| 13 | 7513017 | Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling. | J Exp Med | 1994 | https://conductscience.org/library/papers/7513017 | PubMed |
| 14 | 18063670 | Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. | Ann Rheum Dis | 2008 | https://conductscience.org/library/papers/18063670 | PubMed |
| 15 | 9581795 | Signal transduction by immunoglobulin Fc receptors. | J Leukoc Biol | 1998 | https://conductscience.org/library/papers/9581795 | PubMed |
| 16 | 20483718 | Lupus serum IgG induces skin inflammation through the TNFR1 signaling pathway. | J Immunol | 2010 | https://conductscience.org/library/papers/20483718 | PubMed |
| 17 | 25303149 | Activation of Syk in peripheral blood B cells in patients with rheumatoid arthritis: a potential target for abatacept therapy. | Arthritis Rheumatol | 2015 | https://conductscience.org/library/papers/25303149 | PubMed |
| 18 | 24514912 | Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE. | Nat Rev Rheumatol | 2014 | https://conductscience.org/library/papers/24514912 | PubMed |
| 19 | 20467426 | The SYK tyrosine kinase: a crucial player in diverse biological functions. | Nat Rev Immunol | 2010 | https://conductscience.org/library/papers/20467426 | PubMed |
| 20 | 20222110 | Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice. | Arthritis Rheum | 2010 | https://conductscience.org/library/papers/20222110 | PubMed |
Cited by54
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42266693 | Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect of piceatannol on rheumatoid arthritis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42266693 | PubMed |
| 42093034 | Peripheral blood transcriptomic analysis of patients with rheumatoid arthritis associated interstitial lung disease reveals: distinct molecular signature with evidence of humoral and myeloid immunity. | Arthritis Res Ther | 2026 | https://conductscience.org/library/papers/42093034 | PubMed |
| 42026764 | Syk inhibition limits autoimmunity and abnormal B cell phenotype and function in mice with B cell-specific TRAF3 deficiency. | J Immunol | 2026 | https://conductscience.org/library/papers/42026764 | PubMed |
| 41859124 | B cell receptor signaling in autoimmune rheumatic diseases: regulatory mechanisms and therapeutic targeting. | Front Immunol | 2026 | https://conductscience.org/library/papers/41859124 | PubMed |
| 41689663 | Translational immunothrombosis in autoimmune Heparin-Induced thrombocytopenia: targeting the FcγRIIa-Syk-BTK and complement pathways. | Clin Exp Med | 2026 | https://conductscience.org/library/papers/41689663 | PubMed |
| 41632249 | Beyond inflammation: siRNA strategies for precision targeting in rheumatological disorders. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41632249 | PubMed |
| 41311391 | Targeting pattern recognition receptors for cancer therapy: Mechanisms and strategies. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/41311391 | PubMed |
| 40774947 | Activation of AKT via a dual mechanism enhances the susceptibility of melanoma cells to glucose deprivation. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/40774947 | PubMed |
| 40672966 | Dysregulation of innate and adaptive lymphoid immunity may have implications for symptom attribution and predict responses to targeted therapies in neuropsychiatric systemic lupus erythematosus. | J Transl Autoimmun | 2025 | https://conductscience.org/library/papers/40672966 | PubMed |
| 40591213 | Targeting rheumatoid arthritis risk factors with phytochemicals: an anti-inflammatory perspective. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/40591213 | PubMed |
| 40506261 | Association between Lyn tyrosine kinase and renal injury in patients with systemic lupus erythematosus. | Ren Fail | 2025 | https://conductscience.org/library/papers/40506261 | PubMed |
| 40276509 | Uncovering the mysteries of human gamma delta T cells: from origins to novel therapeutics. | Front Immunol | 2025 | https://conductscience.org/library/papers/40276509 | PubMed |
| 39388044 | Kidney injury: the spleno-renal connection and splenic tyrosine kinase. | J Nephrol | 2024 | https://conductscience.org/library/papers/39388044 | PubMed |
| 39115425 | Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy-Induced Immune-Related Adverse Events in Melanoma. | Clin Cancer Res | 2024 | https://conductscience.org/library/papers/39115425 | PubMed |
| 38445695 | A Review on Pyrazole Derivatives Used in the Treatment of Rheumatoid Arthritis: Recent Advancement and Drug Development. | Curr Rheumatol Rev | 2025 | https://conductscience.org/library/papers/38445695 | PubMed |
| 37810632 | Prognostic biomarker SYK and its correlation with immune infiltrates in glioma. | Exp Ther Med | 2023 | https://conductscience.org/library/papers/37810632 | PubMed |
| 37701568 | Immunoglobulin G inhibits glucocorticoid-induced osteoporosis through occupation of FcγRI. | iScience | 2023 | https://conductscience.org/library/papers/37701568 | PubMed |
| 37301715 | Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibition. | Eur J Cancer | 2023 | https://conductscience.org/library/papers/37301715 | PubMed |
| 37256120 | Ras family signaling pathway in immunopathogenesis of inflammatory rheumatic diseases. | Front Immunol | 2023 | https://conductscience.org/library/papers/37256120 | PubMed |
| 36972009 | Targeted Small Molecules for Systemic Lupus Erythematosus: Drugs in the Pipeline. | Drugs | 2023 | https://conductscience.org/library/papers/36972009 | PubMed |
Genes27
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27014261
GET https://conductscience.org/api/papers/v1/27014261/references?page=2